Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

The presented article describes data from secondary analyses, related to the research article entitled ?Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients? [1]. We present detailed data regarding the socio-de...

Descripción completa

Detalles Bibliográficos
Autores: Vázquez Bourgon, Javier|||0000-0002-5478-3376, Ortiz García de la Foz, Víctor, Suarez Pereira, Irene, Iruzubieta, Paula, Arias Loste, María Teresa|||0000-0001-8864-3833, Setién Suero, María Esther, Ayesa Arriola, Rosa, Gómez Revuelta, Marcos, Crespo García, Javier|||0000-0001-8248-0172, Crespo Facorro, Benedicto|||0000-0001-9709-1276
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/21896
Acceso en línea:http://hdl.handle.net/10902/21896
Access Level:acceso abierto
Palabra clave:Cannabis
Psychosis
Liver
Liver steatosis
NAFLD
Descripción
Sumario:The presented article describes data from secondary analyses, related to the research article entitled ?Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients? [1]. We present detailed data regarding the socio-demographic and baseline clinical characteristics of a sample of 390 drug-naïve patients with a first episode of non-affective psychosis, and the differences between cannabis users and non-users in those characteristics. Tables also show the results from cross-sectional and longitudinal statistical analyses exploring the relation between cannabis consumption and liver function, after excluding those patients with hazardous alcohol drinking.